Home
HALO Diagnostics

HALO Diagnostics Market Share Analysis for May 2026

Treating prostate cancer with Laser Focal Therapy (laser ablation surgery) has lower risks of incontinence & impotence, requires no anesthesia.

Health > Health - Other

Domainhalodx.com

Year Founded2019

Employees201 - 500

Annual Revenue--

HALO Diagnostics

HALO Diagnostics (including company regionals)

halodx.com

See more website traffic and engagement information

Total visits to HALO Diagnostics's top domains

Understand HALO Diagnostics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

halodx.com25.4K

See more with Sales Intelligence

Avg. visit duration in HALO Diagnostics's top domains

Analyze HALO Diagnostics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

halodx.com00:03:02

See more with Sales Intelligence

Avg. pageviews on HALO Diagnostics's top domains

See how HALO Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

halodx.com1.82

See more with Sales Intelligence

HALO Diagnostics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

indicalab.comCompany NameIndica LabsEmployees51 - 200HQUnited States, New Mexico, AlbuquerqueAnnual revenue$10M - $15MTotal visits16.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by HALO Diagnostics

These are the website technologies, by industry, used by HALO Diagnostics top domains

Advertising (8)

DoubleClick

Widget (7)

Twemoji

Content Management System (5)

WordPress

Conversion & Analytics (4)

Google Analytics

More Technologies

14

See all

News & Signals from HALO Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCLS AB partners with Halo Dx, Inc..Clinical Laserthermia Systems announces initiation of prostate cancer clinical study in collaboration with U.S based HALO Diagnostics.

NewsHalo Dx, Inc. partners with Bayer AG.October 17, 2023 - Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader in radiology, to join QUANTI, Bayer's Phase III clinical development program for gadoquatrane.

NewsHalo Dx, Inc. hired Thomas P. Slavin as chief scientific officer on Oct 12th '23.HALO Precision Diagnostics appoints Thomas P. Slavin, M.D., as chief scientific officer.